- Home
- WRN vs GNFT Comparison
WRN vs GNFT Comparison
Compare WRN & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRN
- GNFT
- Stock Information
- Founded
- WRN 2006
- GNFT 1999
- Country
- WRN Canada
- GNFT France
- Employees
- WRN N/A
- GNFT N/A
- Industry
- WRN Metal Mining
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRN Basic Materials
- GNFT Health Care
- Exchange
- WRN Nasdaq
- GNFT Nasdaq
- Market Cap
- WRN 249.2M
- GNFT 249.0M
- IPO Year
- WRN N/A
- GNFT 2019
- Fundamental
- Price
- WRN $1.21
- GNFT $5.39
- Analyst Decision
- WRN Strong Buy
- GNFT Strong Buy
- Analyst Count
- WRN 1
- GNFT 1
- Target Price
- WRN $4.25
- GNFT $13.00
- AVG Volume (30 Days)
- WRN 178.4K
- GNFT 20.1K
- Earning Date
- WRN 11-01-2024
- GNFT 09-19-2024
- Dividend Yield
- WRN N/A
- GNFT N/A
- EPS Growth
- WRN N/A
- GNFT N/A
- EPS
- WRN N/A
- GNFT 0.47
- Revenue
- WRN N/A
- GNFT $86,225,222.00
- Revenue This Year
- WRN N/A
- GNFT $155.44
- Revenue Next Year
- WRN N/A
- GNFT N/A
- P/E Ratio
- WRN N/A
- GNFT $11.07
- Revenue Growth
- WRN N/A
- GNFT 175.45
- 52 Week Low
- WRN $0.95
- GNFT $2.89
- 52 Week High
- WRN $1.66
- GNFT $6.05
- Technical
- Relative Strength Index (RSI)
- WRN 51.60
- GNFT 60.67
- Support Level
- WRN $1.20
- GNFT $5.06
- Resistance Level
- WRN $1.31
- GNFT $6.05
- Average True Range (ATR)
- WRN 0.05
- GNFT 0.31
- MACD
- WRN -0.00
- GNFT 0.04
- Stochastic Oscillator
- WRN 28.57
- GNFT 65.60
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.